RxDoctor Payments Data

Andrew Blitzer, MD

Otolaryngology · Hackensack, NJNPI 1114023520

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,300 of the $8,783 with a category attached, or 60.3%. AbbVie accounts for 68.1% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2020 at $4,800 and has fallen 95.7% since, to $206 in 2025. Among otolaryngology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,783in general payments, 2019–2025

Across 30 payments — averaging $292.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$6K
  • Merz Pharmaceuticals, LLC$2K
  • Merz North America, Inc.$302
  • Merck$40
  • Acera Surgical, Inc.$27
$30,833in research payments, 2019–2025

Across 2 payments — averaging $15,417 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$31K

What the payments were for

  • Consulting fees$5,30060%
  • Travel & lodging$2,04623%
  • Food & beverage$1,38016%
  • Education$571%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)13$5,980
Merz Pharmaceuticals, LLC8$2,433
Merz North America, Inc.6$302
Merck2$40
Acera Surgical, Inc.1$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,783 in reported general payments places this provider in the 95th percentile of 232 otolaryngology providers in New Jersey.

See all otolaryngology providers in New Jersey

Medicare billing

Part B allowed, 2024
$134,965
Medicare patients
83
Services billed
13,650

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other otolaryngology in Hackensack

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →